Expertise in
6
conditions

Christophe Mariat

Saint-etienne-de-valoux, FR 
Expertise in
6
conditions
Saint-etienne-de-valoux, FR 

Overview

Christophe Mariat practices in Saint-etienne-de-valoux, France. Mr. Mariat is highly rated in 6 conditions, according to our data. His top areas of expertise are IgA Nephropathy, Glomerulonephritis, Chronic Kidney Disease, Kidney Transplant, and Nephrectomy.

His clinical research consists of co-authoring 186 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Saint-etienne-de-valoux, France
Other Locations
Saint Étienne, France
Lyon, France
Saint-priest-la-vetre, France
Clermont-ferrand, France
Saint-jean-saint-germain, 42055, France
Nantes, 44093, France
University of St Etienne
Saint-etienne, France
Strasbourg, France
CHU Besançon
Besancon, France
Boulogne-billancourt, France
Reims, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

Blood Innate Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
Blood Innate Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
Enrollment Status: Completed
Publish Date: March 24, 2026
Intervention Type: Other
Study Phase: Not Applicable
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease: a Prospective, Multicenter, Randomized, Open-label, Clinical Trial
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease: a Prospective, Multicenter, Randomized, Open-label, Clinical Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 20, 2026
Intervention Type: Other, Drug
Study Phase: Phase 3
L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury: a Multicentre, Randomized, 2-parallel Group, Superiority Trial
L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury: a Multicentre, Randomized, 2-parallel Group, Superiority Trial
Enrollment Status: Terminated
Publish Date: August 26, 2025
Intervention Type: Drug
Study Drug: L-Carnitine
Study Phase: Phase 3
Impact of the Use of Remote Monitoring in the Follow-up of the Renal Transplant Patient.
Impact of the Use of Remote Monitoring in the Follow-up of the Renal Transplant Patient.
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2025
Intervention Type: Other
Study Phase: Not Applicable
Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers on the Occurrence of S. Aureus Infections in Hemodialysis Patients
Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers on the Occurrence of S. Aureus Infections in Hemodialysis Patients
Enrollment Status: Terminated
Publish Date: December 18, 2024
Intervention Type: Other, Drug
Study Phase: Phase 4
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Phase: Phase 3
Double-blind Placebo-Controlled Randomized Clinical Trial of Mineralocorticoid Receptor Blockade With Eplerenone After Renal Transplantation : Effect on Graft Function at 3 Months.
Double-blind Placebo-Controlled Randomized Clinical Trial of Mineralocorticoid Receptor Blockade With Eplerenone After Renal Transplantation : Effect on Graft Function at 3 Months.
Enrollment Status: Active_not_recruiting
Publish Date: June 18, 2023
Intervention Type: Drug
Study Drug: Eplerenone
Study Phase: Phase 3
Interest of Systematic Transplantectomy Versus Conventional Care After Kidney Graft Failure
Interest of Systematic Transplantectomy Versus Conventional Care After Kidney Graft Failure
Enrollment Status: Completed
Publish Date: November 21, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
Ex Vivo Evaluation of Immunity Activation Face to Staphylococcus Aureus Antigens and Adjuvants of a Vaccine Candidate in Cells From Haemodialysis Patients
Ex Vivo Evaluation of Immunity Activation Face to Staphylococcus Aureus Antigens and Adjuvants of a Vaccine Candidate in Cells From Haemodialysis Patients
Enrollment Status: Completed
Publish Date: December 17, 2020
Intervention Type: Biological
Study Phase: Not Applicable
Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis : a Predictive Factor of Clinical Outcome? (MONITUX)
Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis : a Predictive Factor of Clinical Outcome? (MONITUX)
Enrollment Status: Terminated
Publish Date: November 16, 2020
Intervention Type: Other
View 9 Less Clinical Trials

186 Total Publications

Creatinine, cystatin C or both to estimate glomerular filtration rate in kidney transplant recipients?
Creatinine, cystatin C or both to estimate glomerular filtration rate in kidney transplant recipients?
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: February 19, 2026

Frequently Asked Questions about Christophe Mariat

Is Christophe Mariat a top-rated expert for Kidney Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Christophe Mariat is classified as an Elite expert for Kidney Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christophe Mariat participate in research or clinical trials?

Yes. Christophe Mariat has published 186 articles and abstracts on conditions like Kidney Transplant. You can view a list of Christophe Mariat's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mariat's expertise for a condition
ConditionClose
View All 26 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile